Caseflicks

Court of Appeals for the Second Circuit • 2007

ATSI Communications, Inc. v. Shaar Fund, Ltd.

493 F.3d 87 | 2007 U.S. App. LEXIS 16382

Full access

Unlock the video and quiz

The written brief is free to read below. Subscribe to watch the video explainer and take the quiz.

Takeaway

In short, this case holds that a plausible theory of a “death spiral” financing scheme is not enough: a securities-fraud plaintiff must plead particular deceptive market acts, a strong inference of scienter, and a concrete causal link between each alleged misstatement and the claimed loss.

Background

ATSI, a financially troubled telecommunications company, raised capital by selling “floorless” convertible preferred stock to the Shaar Fund and Rose Glen. The securities could be converted into common shares at a discount tied to recent market prices, so a falling common-stock price yielded more shares upon conversion. ATSI alleged that the investors falsely portrayed themselves as reputable, long-term investors; falsely represented their investor status and intentions regarding short sales; then shorted ATSI stock, converted their preferred shares, and used the converted shares to cover their short positions. ATSI called this a “death spiral” financing scheme.

ATSI relied on falling stock prices, heavy trading volume, stock-price declines around conversion dates, adverse stock reactions to good news, and settlement data to infer manipulation. It also alleged that Trimark, ATSI’s principal market maker, participated in the scheme. ATSI brought federal claims under § 10(b) and Rule 10b-5 for misrepresentation and market manipulation, as well as § 20(a) control-person claims and state-law claims.

The Southern District of New York dismissed ATSI’s amended complaints with prejudice under Rule 12(b)(6), concluding that the securities-fraud allegations did not satisfy Rule 9(b) or the PSLRA. ATSI had already received several opportunities to amend. The Second Circuit affirmed.

Issues

Issue #1

Whether ATSI adequately pleaded Rule 10b-5 market manipulation by the investors and their affiliates.

Holding

No. ATSI did not plead particular manipulative acts or facts supporting a strong inference that the defendants intended to deceive the market.

Reasoning

Market manipulation under § 10(b) means intentional conduct that artificially affects a security’s price and deceives investors about the genuine forces of supply and demand. The central question is whether defendants engaged in market activity that sent a false pricing signal, such as wash sales, matched orders, or rigged prices. A manipulation claim cannot rest solely on misstatements or omissions; it requires actual market activity designed to create a false appearance of market valuation.

Short selling, even in substantial volume, is not inherently manipulative. It can add liquidity and help bring an overvalued stock toward its intrinsic value. Likewise, buying floorless convertible securities, either alone or together with short selling, is not inherently unlawful. These instruments may provide needed financing to distressed issuers and may transparently hedge a short position when their terms are disclosed. The plaintiff had to allege something more—conduct deliberately creating a false impression of supply, demand, or price.

Because manipulation sounds in fraud, Rule 9(b) required ATSI to plead the nature, purpose, and market effect of the allegedly fraudulent conduct, as well as each defendant’s role, with particularity. The court recognized that some manipulation facts may lie exclusively with defendants, so a plaintiff need not identify every trade at the pleading stage. But the complaint still had to state, to the extent possible, what acts occurred, who performed them, when they occurred, and how they affected the market. The PSLRA separately required particular facts creating a strong inference of scienter.

ATSI’s allegations of high-volume trading and price declines were too speculative. The complaint did not identify how many shares the defendants sold, when they sold them, or how their sales caused the price drop. The incorporated SEC filings also undercut the inference: during the April 2000 high-volume period, the Shaar Fund reportedly held far fewer common shares than would be needed to account for the alleged trading volume, and its later-convertible Series D shares had not yet been converted.

The alleged price drops before conversion dates did not plausibly establish manipulation. ATSI assumed that, absent wrongdoing, its share price and trading volume should have remained stable by comparison with earlier periods. The court rejected that premise because securities prices and trading volumes naturally fluctuate; a decline during a conversion look-back period, without particular facts tying it to defendants’ deceptive conduct, does not show manipulation.

ATSI’s assertion that its stock sometimes fell despite favorable news also failed. The theory did not require a direct connection between the news and defendants, but ATSI still had to plead a particular connection between the negative price reaction and something defendants actually did. Otherwise, holders of convertible preferred stock could face manipulation suits whenever an issuer believed its stock reacted unexpectedly to news.

The settlement data likewise did not support a non-speculative inference of wash trades, matched trades, phantom shares, or similar deceptive activity. ATSI alleged that millions of shares traded in excess of settlement over ten days, but it did not identify any particular manipulative transaction or explain how a defendant caused an artificial market effect. The data also had an innocent explanation, including internal broker-dealer settlements, and the stock price remained unchanged over the relevant period.

The complaint also failed the PSLRA scienter standard. The opportunity to profit from a floorless convertible is common to every investor holding that instrument and therefore does not establish a concrete motive to manipulate. The more compelling inference was that ATSI and the defendants entered into mutually beneficial financing arrangements, not that the defendants deliberately deceived the market. Since ATSI did not adequately allege short sales or other manipulative acts, it also lacked strong circumstantial evidence of manipulative intent.

Issue #2

Whether ATSI adequately pleaded market manipulation by Trimark, the principal market maker in ATSI stock.

Holding

No. ATSI alleged neither particular manipulative acts by Trimark nor facts creating a strong inference of Trimark’s scienter.

Reasoning

ATSI alleged only that Trimark was the principal market maker, knew or should have known about the alleged scheme, and was believed to be a cooperating broker-dealer. Those generalized assertions did not identify any trading, order, transaction, or other act by Trimark that distorted ATSI’s market. They also did not support the PSLRA-required strong inference that Trimark intended to manipulate the stock price or deceive investors.

Issue #3

Whether ATSI could base Rule 10b-5 misrepresentation claims on the defendants’ pre-contractual oral representations.

Holding

No. The merger clauses barred ATSI, a sophisticated party, from establishing reasonable reliance on prior oral representations omitted from the integrated transaction agreements.

Reasoning

The registration-rights agreements stated that the written transaction documents contained the parties’ complete promises, restrictions, warranties, and undertakings and superseded prior agreements. ATSI was a sophisticated investor engaging in private placements of complex convertible securities. Under Second Circuit precedent, such a party cannot reasonably rely on prior representations that an integrated agreement does not include. The court therefore rejected claims based on alleged oral assurances that defendants were long-term investors or would not depress ATSI’s stock price.

Issue #4

Whether ATSI adequately pleaded that the Shaar Fund’s contractual promise concerning short positions was false when made.

Holding

No. ATSI did not allege particular facts showing that the Shaar Fund secretly intended not to perform when it made the promise.

Reasoning

A broken contractual promise may establish a breach of contract, but it is securities fraud only if the speaker secretly intended not to perform, or knew it could not perform, when it made the promise. ATSI alleged that the Shaar Fund promised not to enter short positions before closing and not to use converted shares to settle certain preexisting short positions. But its allegation that defendants actually engaged in short selling was speculative for the same reasons its manipulation allegations were insufficient.

ATSI also tried to infer fraudulent intent from claimed “death spiral” activity involving the defendants’ other investments. The complaint did not identify particular companies, dates, acts by defendants, or facts showing that defendants caused the cited stock-price declines. Merely describing a mechanism by which floorless convertibles could be exploited, combined with the poor performance of risky companies in defendants’ portfolios, did not explain why this contractual promise was false when made.

Issue #5

Whether ATSI adequately pleaded loss causation from the Shaar Fund’s alleged false representation that it was an accredited investor.

Holding

No. ATSI did not connect its claimed economic losses to the subject of the alleged accreditation misrepresentation.

Reasoning

A Rule 10b-5 plaintiff must plead both transaction causation and loss causation. Transaction causation asks whether the plaintiff would have entered the transaction but for the misrepresentation. Loss causation requires a proximate causal connection between the misconduct and the economic loss: the loss must be foreseeable and result from the materialization of the risk concealed by the false statement.

ATSI alleged that its stock price collapsed, its ability to raise capital was impaired, and it sold its own securities at depressed prices. But it did not explain how the Shaar Fund’s alleged lack of accredited-investor status caused any of those losses. Recasting the allegation as one that the defendants used accreditation to appear trustworthy may explain why ATSI entered the transaction, but it does not establish that the concealed fact—lack of accredited status—caused ATSI’s later losses.

Issue #6

Whether ATSI adequately pleaded misrepresentation claims against Rose Glen and CCM.

Holding

No. The claims were barred by the merger clauses, insufficiently pleaded, or time-barred.

Reasoning

As with the Shaar Fund transaction, the merger clauses foreclosed reasonable reliance on Rose Glen’s and CCM’s alleged oral, pre-contractual assurances. ATSI also did not allege particular facts showing that Rose Glen’s statement that it purchased for its own account, rather than with a present view toward public distribution, was false when made. Indeed, the contract expressly reserved Rose Glen’s right to dispose of the securities at any time through a registration statement or exemption.

ATSI’s bait-and-switch allegation—that Rose Glen initially proposed a $10 million investment but funded only $2.5 million at closing—was time-barred under the then-applicable limitations period because ATSI knew the relevant facts when it signed the closing documents in October 2000 but did not sue Rose Glen until October 2002. The claim also failed on the merits because the draft term sheet expressly made Rose Glen’s funding obligation subject to satisfactory due diligence in its sole discretion.

Issue #7

Whether ATSI stated a § 20(a) control-person claim.

Holding

No. Without a well-pleaded primary securities-law violation, ATSI could not establish control-person liability.

Reasoning

To state a prima facie § 20(a) claim, a plaintiff must allege a primary violation by the controlled person, control by the defendant over that violator, and culpable participation in the fraud. Because ATSI failed to plead an underlying Rule 10b-5 violation, its control-person claims necessarily failed without the need to resolve the remaining elements.

Issue #8

Whether the district court abused its discretion by dismissing with prejudice rather than granting ATSI another opportunity to amend.

Holding

No. ATSI had already received adequate opportunities to cure its pleading defects.

Reasoning

Although courts commonly allow at least one opportunity to replead a fraud claim dismissed under Rule 9(b), ATSI had more than that opportunity. In the first action, it submitted three amended complaints after the district court had already identified similar Rule 9(b) and PSLRA deficiencies; the complaint in the second action was largely identical to the final amended complaint in the first. The district court therefore acted within its discretion in denying further leave to amend.